Skip to content

NEUROMODULATORY EFFECTS OF ESTRADIOL AND PROGESTERONE ON KETAMINE'S ACTION IN FEMALE RAT BRAIN

N. González, P. Ramirez, Esther Berenice Vargas Hunger, Ricardo J. Cabrera

Proceedings of the Second Southern Science Conference. Book B 2024 DOI: 10.48141/sscon_48_2024.pdf (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Controlled animal experiment (preclinical study) Peer reviewed
Population Ovariectomized female rats
Interventions Ketamine Estradiol (E2) Progesterone (P4)
Measures Open field behavioral test (locomotor activity), EthoWatcher software
Topics Esketamine Ketamine
Key findings Repeated ketamine administration increased locomotor activity in ovariectomized female rats, and estradiol and progesterone supplementation further raised locomotor activity in sensitized animals. The authors argue that these hormones enhance ketamine-induced potentiation via genomic and non-genomic interactions, producing what they call positive neuroadaptive plasticity.

Abstract

Ketamine-induced psychotic episodes with hallucinations and sensory dissociation when abused. In rats, prolonged intraperitoneal ketamine (K) administration increases locomotor activity. Neuroactive steroids modulate responses to such drugs. This study aimed to investigate ketamine-induced neuroadaptive effects and neuromodulatory phenomena from Estradiol (E2) and Progesterone (P4) in female rats. Female rat ovariectomies (OVX) were performed, followed by open field behavioral tests to assess locomotor activity (LA), which were analyzed using the EthoWatcher software. Significant LA increases were observed in control EP and K groups vs. C. E2 and P4 further raised LA in sensitized OVX animals. The results demonstrate that E2 and P4 supplementation enhances potentiation, indicating genomic and non-genomic interactions, leading to positive neuroadaptive plasticity with K.

Comparable studies

Other preclinical and animal studies on ketamine, most cited first.

Explore topics